Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#3081 An Atypical Presentation of a Neuroendocrine Carcinoma of Unknown Origin
Introduction: Neuroendocrine carcinomas (NEC) of unknown primary site are uncommon. Most arise from an occult/clinically undetectable primary. Primary NEC of genitourinary tract are rare. High-grade (HG) carcinoms, are rapidly growing and aggressive but usually responsive to platinum-based combination chemotherapy.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Da Silva Dias D, Gosálbez B,
Keywords: .,
Introduction: Neuroendocrine tumors (NET) arise from a variety of different organs and have a steadily increasing incidence in the last 3 decades. 13% of NETs have unknown primary sites.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Enache O, Martin S, Lambrescu I, Sirbu A, Constantin T,
Keywords: neuroendocrine, somatostatin analogs,
Introduction: Over treatment radionuclide therapy (PRRT) of metastatic neuroendocrine neoplasm (NEN).
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Strzelczyk J, Poczkaj K, Rosiek V, Kos-Kudła B,
Keywords: neuroendocrine neoplasm, metastases, radionuclide therapy,
Introduction: Neuroendocrine neoplasms of unknown primary (NENs-UP) account for 10-13% of all NENs and show different biologic behavior, histologic appearance and clinical outcome.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Zilli A
Authors: Massironi S, Fanetti I, Cavalcoli F, Zilli A, Conte D,
Keywords: Neuroendocrine tumors, unknown primary,
#1237 Risk Factors for Survival from Neuroendocrine Neoplasia with Unknown Primary Tumor Site
Introduction: Neuroendocrine neoplasia (NEN) with unknown primary site (NEN-CUP) may have a poor prognosis. We evaluated the clinical presentation, therapy, outcome, and risk factors for adverse outcomes in patients with NEN-CUP.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Begum N
Authors: Begum N, Wellner U, Thorns C, Hoffmann M, Bürk C,